Team
–
Rounds
–
Total raised
–
About
Denovo Sciences builds a reinforcement-learning platform that generates and screens candidate small molecules against protein or RNA targets for pharmaceutical clients, and plans to develop its own drug candidates. The company came out of the FAST ASCENT program in Armenia and was selected for EU4Innovation's VivaTech 2026 delegation. Co-founders are Hovakim Zakaryan (CEO), Mher Matevosyan (CTO) and Vardan Harutyunyan.